VITROS CHEMISTRY PRODUCTS NA+ SLIDES
Received Apr 9, 2026 · Event occurred Mar 16, 2026
Report 1319809-2026-00041 · MDR key 24833171
Device
Generic name
In-vitro Diagnostics
Manufacturer
Ortho-clinical Diagnostics, Inc.Catalog number
8379034
Lot number
4209-1181-8890
Product problems
- High Test Results
Patient
NA · Unknown
- No Clinical Signs, Symptoms or Conditions
Narrative
Description of Event or Problem
A CUSTOMER CONTACTED THE ORTHO CLINICAL DIAGNOSTICS (ORTHO) TECHNICAL SOLUTION CENTER (TSC) TO REPORT A HIGHER THAN EXPECTED SODIUM RESULT OBTAINED FROM A NON-VITROS BIORAD QUALITY CONTROL FLUID PROCESSED USING VITROS CHEMISTRY PRODUCTS SODIUM (NA+) SLIDES LOT 4209-1181-8890 ON A VITROS 5600 INTEGRATED SYSTEM. BIORAD LOT 56770 L1 RESULT OF 142.8 MMOL/L VS AN EXPECTED RESULT OF 110.0 MMOL/L BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THEY WERE TO OCCUR UNDETECTED ON PATIENT SAMPLES. THE HIGHER THAN EXPECTED VITROS NA+ RESULT WAS OBTAINED FROM A QUALITY CONTROL FLUID AND WAS NOT REPORTED FROM THE LABORATORY. THERE HAVE BEEN NO ALLEGATIONS OF PATIENT HARM AS A RESULT OF THIS EVENT. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC (ORTHO) COMPLAINT NUMBER (B)(4) AND REPORTABILITY ASSESSMENT (B)(4).
Additional Manufacturer Narrative
THE INVESTIGATION HAS DETERMINED THAT A HIGHER THAN EXPECTED SODIUM RESULT WAS OBTAINED FROM A NON-VITROS BIORAD QUALITY CONTROL FLUID PROCESSED USING VITROS CHEMISTRY PRODUCTS SODIUM (NA+) SLIDES LOT 4209-1181-8890 ON A VITROS 5600 INTEGRATED SYSTEM. THE INVESTIGATION COULD NOT DETERMINE A DEFINITIVE ASSIGNABLE CAUSE OF THE EVENT. BASED ON UNACCEPTABLE HISTORICAL QUALITY CONTROL RESULTS, A VITROS NA+ LOT 4209-1181-8890 PERFORMANCE ISSUE CANNOT BE RULED OUT AS A CONTRIBUTOR OF THE EVENT. THE RESULTS OF DIAGNOSTIC PRECISION TESTING PERFORMED ON THE VITROS 5600 SYSTEM WERE WITHIN ORTHO ACCEPTABLE GUIDELINES. THEREFORE, AN INSTRUMENT RELATED ISSUE IS NOT LIKELY A CONTRIBUTING FACTOR OF THE EVENT. A CALIBRATION RELATED ISSUE CANNOT BE RULED OUT AS A CONTRIBUTING FACTOR AS QUALITY CONTROL RESULTS RETURNED TO EXPECTATIONS FOLLOWING A RECALIBRATION EVENT. HOWEVER, QC RESULTS USING THE INITIAL CALIBRATION WERE WITHIN EXPECTATIONS PRIOR TO THE DATE OF THE EVENT. A PRE-ANALYTICAL FLUID MIX-UP COULD NOT BE RULED OUT AS A CONTRIBUTOR OF THE EVENT AS THE CUSTOMER WAS UNABLE TO CONFIRM OR RULE OUT A FLUID MIX-UP. AN ISSUE WITH THE BIORAD CONTROL FLUID CANNOT BE RULED OUT AS A CONTRIBUTOR OF THE EVENT AS RESULTS HAD RETURNED TO EXPECTATIONS USING A FRESH VIAL OF THE BIORAD CONTROL. AN ISSUE RELATED TO THE VITROS ELECTROLYTE REFERENCE FLUID (ERF) CANNOT BE RULED OUT AS A CONTRIBUTING FACTOR OF THE EVENT AS QC RESULTS RETURNED TO EXPECTATIONS FOLLOWING REPLACEMENT OF THE VITROS ERF RESERVOIR. IT IS UNKNOWN IF THE VITROS ERF RESERVOIR HAD INITIALLY BEEN REPLACED ON THE INSTRUMENT ON THE DATE OF THE EVENT PRIOR TO THE HIGHER THAN EXPECTED CONTROL RESULT BEING OBTAINED. ACCORDING TO THE VITROS ERF INSTRUCTIONS FOR USE, THE VITROS ERF IS STABLE FOR < OR = 24 HOURS ON THE INSTRUMENT. CONTINUAL TRACKING AND TRENDING OF COMPLAINTS HAS NOT IDENTIFIED ANY SIGNALS THAT WOULD POINT TO A POTENTIAL SYSTEMIC ISSUE WITH VITROS NA+ LOT 4209-1181-8890.